BBHC
Brown Brothers Harriman & Co Portfolio holdings
AUM
$15.6B
1-Year Return
17.71%
This Quarter Return
+3.58%
1 Year Return
+17.71%
3 Year Return
+77.24%
5 Year Return
+124.29%
10 Year Return
+261.89%
AUM
$13.3B
AUM Growth
+$250M
(+1.9%)
Cap. Flow
-$75.6M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
41.56%
Holding
1,256
New
97
Increased
286
Reduced
331
Closed
112
Top Buys
| 1 |
Otis Worldwide
OTIS
|
+$75.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$49.1M |
| 3 |
Adobe
ADBE
|
+$43.4M |
| 4 |
nCino
NCNO
|
+$41.8M |
| 5 |
CBRE Group
CBRE
|
+$20.1M |
Top Sells
| 1 |
Copart
CPRT
|
+$168M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$83.1M |
| 3 |
American Tower
AMT
|
+$22.4M |
| 4 |
Carlisle Companies
CSL
|
+$21.4M |
| 5 |
A.O. Smith
AOS
|
+$19.4M |
Sector Composition
| 1 | Technology | 23.74% |
| 2 | Financials | 20.09% |
| 3 | Healthcare | 13.41% |
| 4 | Industrials | 9.07% |
| 5 | Consumer Discretionary | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Regeneron Pharmaceuticals
REGN
$58.9B
| $509K | ﹤0.01% |
484
-18
| -4% | -$18.9K |
|
377
Vanguard FTSE All-World ex-US ETF
VEU
$49.3B
| $504K | ﹤0.01% |
8,588
+6,068
| +241% | +$356K |
|
378
Hillenbrand
HI
$1.75B
| $496K | ﹤0.01% |
12,400
| – | – |
|
379
Constellation Brands
STZ
$25.2B
| $495K | ﹤0.01% |
1,923
| – | – |
|
380
Hamilton Lane
HLNE
$6.55B
| $493K | ﹤0.01% |
3,986
| – | – |
|
381
PACCAR
PCAR
$51.8B
| $490K | ﹤0.01% |
4,762
| – | – |
|
382
DexCom
DXCM
$29.8B
| $486K | ﹤0.01% |
4,283
-1,404
| -25% | -$159K |
|
383
Vanguard Mid-Cap Growth ETF
VOT
$17.7B
| $480K | ﹤0.01% |
2,093
| – | – |
|
384
Kellanova
K
$27.5B
| $478K | ﹤0.01% |
8,279
+4
| +0% | +$231 |
|
385
Pultegroup
PHM
$26.7B
| $475K | ﹤0.01% |
4,310
| – | – |
|
386
Oneok
OKE
$46.2B
| $473K | ﹤0.01% |
5,798
-806
| -12% | -$65.7K |
|
387
AstraZeneca
AZN
$251B
| $473K | ﹤0.01% |
6,062
+216
| +4% | +$16.8K |
|
388
iShares Russell 2500 ETF
SMMD
$1.65B
| $469K | ﹤0.01% |
7,491
+7,079
| +1,718% | +$443K |
|
389
Valero Energy
VLO
$49.2B
| $467K | ﹤0.01% |
2,979
-764
| -20% | -$120K |
|
390
Vanguard FTSE Europe ETF
VGK
$26.9B
| $456K | ﹤0.01% |
6,834
+260
| +4% | +$17.4K |
|
391
SPDR S&P Biotech ETF
XBI
$5.42B
| $455K | ﹤0.01% |
4,905
| – | – |
|
392
FirstEnergy
FE
$25B
| $454K | ﹤0.01% |
11,864
+7,965
| +204% | +$305K |
|
393
DraftKings
DKNG
$22.7B
| $452K | ﹤0.01% |
11,850
-6,000
| -34% | -$229K |
|
394
Masco
MAS
$15.3B
| $448K | ﹤0.01% |
6,726
-1,144
| -15% | -$76.3K |
|
395
TScan Therapeutics
TCRX
$104M
| $445K | ﹤0.01% |
+76,024
| New | +$445K |
|
396
SPDR Portfolio Emerging Markets ETF
SPEM
$13.5B
| $444K | ﹤0.01% |
11,789
| – | – |
|
397
Pacer Trendpilot US Large Cap ETF
PTLC
$3.39B
| $442K | ﹤0.01% |
8,887
| – | – |
|
398
Prologis
PLD
$103B
| $441K | ﹤0.01% |
3,930
+3,081
| +363% | +$346K |
|
399
Wayfair
W
$11.3B
| $432K | ﹤0.01% |
8,200
| – | – |
|
400
Johnson Controls International
JCI
$70.5B
| $429K | ﹤0.01% |
6,447
+15
| +0.2% | +$997 |
|